Capabilities · Product & process development

Container-closure development

A proposed service scope for primary packaging assessment, connecting component selection, material compatibility and systemic integrity for the intended product.

PlannedCatalogue scope

Illustrative unbranded weighing boat with powder detail.
Illustrative unbranded weighing boat with powder detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Container-closure development is presented as a planned service domain. The exact product formulation, target presentation and intended administration route would determine the specific selection and testing scope.

The initial Boten plan covers specific vial, ampoule and cartridge formats. This broader primary packaging development scope lies outside the initial plan and would require explicit technical confirmation.

Physical fit and chemical compatibility represent distinct evaluation criteria. A sealed system preventing microbial ingress would not automatically indicate the absence of chemical interactions over time.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Glass container systemsAseptic filling of vialsDimensional tolerance and delamination assessments for tubular or moulded glass formats.Catalogue scopePlanned
Elastomeric closuresEvaluation of stoppers and plungers for chemical compatibility and physical machinability.Catalogue scopePlanned
Polymeric syringesPrefilled syringesMaterial screening for plastic container systems and their associated tip caps.Catalogue scopePlanned
Cartridge componentsSingle-chamber cartridgesAssessment of aluminium seals, septa and glass dimensions for injection pens.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Component material selection

Identify appropriate glass, plastic or elastomeric materials based on the target formulation properties.

02 · Process stage

Planned

Dimensional tolerance review

Evaluate the physical fit between selected vials, stoppers and crimped aluminium seals.

03 · Process stage

Planned

Machinability assessment

Determine how the selected components would behave on automated sorting and filling tracks.

04 · Process stage

Planned

Extractables & leachables planning

Design studies to investigate potential chemical migration from packaging materials into the formulation.

05 · Process stage

Planned

Integrity testing strategy

Establish the appropriate techniques for verifying the sealed container maintains a sterile barrier.

06 · Process stage

Planned

Final system specification

Document the approved component combination and the required incoming quality acceptance criteria.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Container-closure integrity testing

Presentation-specific integrity questions and the supporting method.

Explore proposed scope

02PlannedCatalogue scope

Impurities & extractables / leachables

Product, material and packaging-related analytical questions.

Explore proposed scope

03PlannedCatalogue scope

Primary packaging

Blisters, bottles, sachets, tubes and presentation-specific container systems.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Product & presentation
The precise final formulation chemistry and its intended administration setting or device.
Component documentation
Detailed technical drawings, material compositions and safety specifications from the primary supplier.
Facility & systems
Appropriate testing equipment for verifying physical dimensions and system integrity limits.
Process evidence
Defined crimping forces, seating pressures and relevant closure assembly parameter ranges.
Quality responsibilities
Clear accountability for protocol generation, analytical review and final component approval.
Technical agreement
Established boundaries governing the exchange of proprietary packaging data and development results.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating container-closure development service.

Are all component combinations feasible?

No. Specific elastomeric formulations or novel plastic containers might require dedicated processing equipment. Feasibility would depend on a detailed technical review of the proposed system.

What information helps define the question?

Detail the target component drawings, known material sensitivities, formulation pH and any intended delivery device. Confidential component data should only be shared through an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual component development service to a start date.

Does a technical discussion establish supply?

No. Feasibility, scope, material permissions, analytical evidence and an appropriate technical agreement would need to be established before any development service commitment.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma